|Systematic (IUPAC) name|
|14px (what is this?)|
threo-4-Methylmethylphenidate (4-MeTMP) is a stimulant drug related to methylphenidate. It is slightly less potent than methylphenidate and has relatively low efficacy at blocking dopamine reuptake despite its high binding affinity, which led to its investigation as a possible substitute drug for treatment of stimulant abuse (cf. nocaine). On the other hand several other simple ring-substituted derivatives of threo-methylphenidate such as the 4-fluoro and 3-chloro compounds are more potent than methylphenidate both in efficacy as dopamine reuptake inhibitors and in animal drug discrimination assays.
- Wayment, H. K.; Deutsch, H.; Schweri, M. M.; Schenk, J. O. (1999). "Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists?". Journal of Neurochemistry 72 (3): 1266–1274. PMID 10037500. doi:10.1046/j.1471-4159.1999.0721266.x.
- Deutsch, H.; Shi, Q.; Gruszecka-Kowalik, E.; Schweri, M. (1996). "Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs". Journal of Medicinal Chemistry 39 (6): 1201–1209. PMID 8632426. doi:10.1021/jm950697c.
- Schweri, M. M.; Deutsch, H. M.; Massey, A. T.; Holtzman, S. G. (2002). "Biochemical and behavioral characterization of novel methylphenidate analogs". The Journal of Pharmacology and Experimental Therapeutics 301 (2): 527–535. PMID 11961053. doi:10.1124/jpet.301.2.527.
- Davies, H.; Hopper, D.; Hansen, T.; Liu, Q.; Childers, S. (2004). "Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites". Bioorganic & Medicinal Chemistry Letters 14 (7): 1799–1802. PMID 15026075. doi:10.1016/j.bmcl.2003.12.097.